English
Back
Download
Log in to access Online Inquiry
Back to the Top

$Emergent BioSolutions (EBS.US)$ Bavarian Nordic ramping up ...

$Emergent BioSolutions (EBS.US)$ Bavarian Nordic ramping up production to hit 10 mil doses by end of 2025. We're still severely short on vaccines, don't you think?
Africa is currently facing a shortage of supply of mpox vaccines. Africa CDC estimates that currently about 200,000 doses are available compared to a requirement of at least 10 million doses, based on estimates from countries that have prepared vaccination plans.
----------------------------------------------
Danish biotech firm Bavarian Nordic said on Saturday that it plans to ramp up production of its mpox vaccine and work with international health organisations to ensure fair access as the disease has been declared a global public health emergency.
The company, one of the few drug firms that have a mpox vaccine, said it has informed the Africa Centres for Disease Control and Prevention (CDC) that it can manufacture 10 million doses of the vaccine by the end of 2025, and could already supply up to two million doses this year.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
5
Translate
Report
4974 Views
Comment
Sign in to post a comment
"Stock market is filled with individuals who knows the price of everything, but value of nothing."
133Followers
9Following
513Visitors
Follow